stockrowAnteris Technologies Global Corp.
AVR Healthcare Medical Devices
Anteris Technologies Global Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 million, down 29.2% from fiscal 2024.
- Revenue
- +63.3%
- EPS
- +48.3%
- Free cash flow
- −6.84%
- Total debt
- +8.15%
Quarter to June 2026, against a year earlier
Follow AVR
Alert me
Anteris Technologies Global Corp. (AVR) Piotroski F-score
Anteris Technologies Global Corp.'s Piotroski F-score for fiscal 2025 is 2 out of 9: 2 of nine tests of profitability, leverage and efficiency passed.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2025 | 2 | — |
How fiscal 2025’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | (181.58%) | (137.18%) | Fail | 0 |
| Positive operating cash flow | (77.80m) | (61.24m) | Fail | 0 |
| Rising return on assets | (181.58%) | (137.18%) | Fail | 0 |
| Cash flow above net income | 16.34m | 15.05m | Pass | 1 |
| Falling long-term leverage | 0.00 | 0.00 | Fail | 0 |
| Rising current ratio | 0.73 | 4.51 | Fail | 0 |
| No new shares issued | 36,911,500 | 20,252,900 | Fail | 0 |
| Rising gross margin | 70.26% | 46.84% | Pass | 1 |
| Rising asset turnover | 0.04 | 0.05 | Fail | 0 |
| Piotroski F-score | Weak — most fundamentals deteriorated | 2 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| TCMD Tactile Systems Technology, Inc. compare | 8 |
| DCTH Delcath Systems, Inc. compare | 7 |
| MASS 908 Devices Inc. compare | 5 |
| NPCE NeuroPace, Inc. compare | 5 |
| CERS Cerus Corporation compare | 5 |
| SGHT Sight Sciences, Inc. compare | 5 |
| SENS Senseonics Holdings, Inc. compare | 5 |
| CTKB Cytek Biosciences, Inc. compare | 4 |
| AVR Anteris Technologies Global Corp. | 2 |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover